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Abstract 
Purpose 
This study investigated an association of post-radiochemotherapy (RCT) PET radiomics with local tumor 
control in head and neck squamous cell carcinoma (HNSCC) and evaluated the models against two 
radiomics software implementations. 
Materials and methods 
649 features, available in two radiomics implementations and based on the same definitions, were 
extracted from HNSCC primary tumor region in 18F-FDG PET scans 3 months post definitive RCT (training 
cohort n=128, validation cohort n=50) and compared using the intraclass correlation coefficient (ICC). Local 
recurrence models were trained, separately for both implementations, using principal component analysis 
(PCA) and the least absolute shrinkage and selection operator. The reproducibility of the concordance 
indexes (CI) in univariable Cox regression for features preselected in PCA and the final multivariable models 
was investigated using respective features from the other implementation.   
Results  
Only 80 PET radiomic features yielded ICC>0.8 in the comparison between the implementations. The 
change of implementation caused high variability of CI in the univariable analysis. Both final models 
performed equally well in the training and validation cohorts (CI>0.7) independent of radiomics 
implementation.  
Conclusion 
The two post-RCT PET radiomic models, based on two different software implementations, were 
prognostic for local tumor control in HNSCC. However, 88% of the features was not reproducible between 
the implementations. 
 
Keywords: post-radiochemotherapy 18F-FDG PET, radiomics, local tumor control modelling, software 
implementation, reproducibility 
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Introduction 
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers worldwide with 
tobacco and alcohol consumption as well as HPV infection being the important risk factors. The standard 
of care for patients with locally advanced HNSCC is definitive radiochemotherapy (RCT). The locoregional 
recurrence rate is high, exceeding 50% in HPV negative oropharyngeal carcinoma and non-oropharyngeal 
cancers [1, 2]. A meta-analysis of post-RCT 18F-fluorodeoxyglucose positron emission tomography (18F-
FDG PET) studies reported sensitivity and specificity of around 80% in respect to detection of local tumor 
recurrence or persistence in HNSCC [3]. Additionally, post-RCT FDG PET has been shown to correlate with 
overall survival [4]. 
Radiomics, a high throughput method for quantification of medical images, has been shown a promising 
input for treatment response modelling [5-11]. It is based on a comprehensive and quantitative analysis 
of a region of interest performed on different levels: shape, intensity, texture and filter-based analysis. 
Radiomics is a rapidly growing field of research. However, the studies have been predominantly performed 
in independent single-institution settings and consequently, the importance of workflow standardization 
has been indicated [5, 6]. 
Radiomics analysis requires several image pre-processing steps such as region of interest segmentation 
and extraction as well as image interpolation and discretization. These steps together with image 
acquisition and reconstruction parameters may influence radiomic features and therefore 
interchangeability of derived models (i.e. radiomic signatures) [12, 13]. Many institutions use different 
software packages for the analysis, which are often in-house developed. Although the implementations 
are based on the same mathematical definitions, it is likely that they will produce different results due to 
differences in implementation of algorithms as well as pre-processing [13].  
To base clinical decisions on a prognostic model, its validation is required [14, 15]. Several strategies, 
characterized by different strength, can be used. A cross-validation is often implemented as a first step, 
followed by temporal validation using data from the same institution but from a different period. Finally, 
to achieve an unbiased validation, an external validation in an independent dataset should be performed 
[16]. Most of the radiomics studies have used cross-validation to quantify model performance and so far 
only one model has been validated in an external and independent dataset [17, 18]. Validation is usually 
performed by the same research group, using the same tools and methodology. However, radiomic 
features have been shown to vary with image acquisition parameters, pre-processing and contouring [5, 
6, 12] and (to our knowledge) none of the previously published studies investigated the reproducibility of 
a radiomics-based prognostic model in terms of radiomics software implementation. 
This study hypothesize that the prognostic value of radiomic features is software implementation 
dependent.  First, we investigated whether the 3 months post-RCT follow-up 18F-FDG PET radiomics is 
prognostic for tumor recurrence in HNSCC. Two independent models were trained using two independent 
radiomics implementations and their performance was validated in a separate dataset. Subsequently, the 
reproducibility of these models was evaluated when their respective radiomic features were calculated 
with an independent software implementation.  
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Materials and methods 
Imaging protocol and studied population 
This retrospective analysis was approved by the local ethical commission. HNSCC patients treated with 
definitive radiochemotherapy were enrolled in the study (128 patients in the training and 50 patients in 
the validation cohort). The validation cohort consisted of patients treated in an institutional phase II 
prospective study (NCT01435252) with a standardized imaging protocol (the same slice thickness and 
reconstruction algorithm). Surgery or induction chemotherapy were exclusion criteria (biopsy allowed). 
The characteristic of the studied cohorts is presented in the Table 1. All patients underwent 18F-FDG 
PET/CT imaging prior to the treatment and 3 months after the end of the treatment as a standard follow-
up examination. Depending on patient’s body weight, an activity of 170-470 MBq of 18F-FDG was injected 
intravenously after the measurement of blood sugar level. The PET acquisition was preformed 60 minutes 
after 18F-FDG injection with a 3 minutes scanning time and 15 cm axial field-of-view at each bed position. 
Total acquisition time of the PET was 12-18 min. Images were reconstructed with an iterative algorithm 
(2D or 3D reconstruction in the training cohort and 3D reconstruction in the validation cohort) with an in-
plane pixel size and the slice thickness of 2.73 – 5.47 mm and 3.27 – 4.25 mm, respectively. All data was 
acquired in the same center.  
  Training cohort Validation cohort 
 Total number of patients 128 50 
 Median follow-up (months) 46 (3-156) 16 (3-28) 
 Number of local recurrences 38 (30%) 13 (26%) 
Tumor 
stage 
T1/T2 43 (34%) 6 (12%) 
T3/T4 85 (66%) 44 (88%) 
HPV 
status 
Positive 31 (24%) 22 (44%) 
Negative 36 (28%) 28 (66%) 
Unknown 61 (48%) 0 
Tumor 
site 
Oropharynx 91 (71%) 29 (58%) 
Hypopharynx 22 (17%) 7 (14%) 
Larynx 11 (9%) 7 (14%) 
Oral cavity 4 (3%) 7 (14%) 
Treatment Radiotherapy on average 70 Gy  
(68 – 72 Gy) 
70 Gy 
 Chemotherapy Cisplatin (40 mg/m2, up to 
7 cycles) or cetuximab 
(loading dose 400 mg/m2 
followed by 250 mg/m2 
weekly) 
Cisplatin/cetuximab 
(weekly same doses as in 
training cohort) with or 
without consolidation 
cetuximab (500 mg/m2 
biweekly x 6) 
PET 
scanners 
GE Discovery STE 
GE Discovery 690 
GE Discovery RX 
GE Discovery HR 
GE Discovery LS 
64 (50%) 
10 (8%) 
23 (18%) 
15 (12%) 
16 (12%) 
39 (78%) 
6 (12%) 
5 (10%) 
Table 1. Detailed characteristic of studied cohorts. 
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Image pre-processing and radiomics analysis 
Tumors were semi-automatically segmented in the pre-treatment PET scans using a gradient-based 
method implemented in MIMVISTA (MIM Software Inc., Cleveland, OH, USA). The pre-treatment and post-
treatment scans were rigidly registered and contours were transferred to post-treatment scans. To 
account for differences in image reconstruction grid all scans were rescaled to 5.5 mm cubic voxels using 
linear interpolation. This corresponds to the smallest resolution in the studied dataset. 
The pre-processed images were shared between the institutions. Post-RCT metabolic heterogeneity was 
studied in the region of the primary tumor (Figure 1). Two independent software implementations were 
used: implementation from the University Hospital Zurich (USZ) and the MAASTRO clinic (MAASTRO). In 
total 649 features, which were based on the same definition and available in both implementations, were 
extracted: 
 Shape (n = 8) 
 Intensity-based (n = 17) 
 Texture: the Gray Level Co-occurrence Matrix (GLCM; n = 24), the Neighborhood Gray Tone 
Difference Matrix (NGLTDM; n = 4), the Gray-Level Size Zone Matrix (GLSZM; n = 14), the Gray-
Level Run Length Matrix (GLRLM; n = 14). 
 Filter-based: Wavelet coiflet (n = 568). 
The full list of the extracted features is presented in the supplemental material. A bin size of 0.5 SUV was 
used for image intensity discretization. The consistency of radiomic features calculated in two different 
implementations was studied using the two-way mixed single measures intraclass correlation coefficient 
(ICC). 
 
Figure 1. Scheme of the reproducibility analysis of the local tumor control models using two independent 
radiomics implementation. 
 
Features preselection and comparison of the features’ prognostic power between the radiomics 
implementations 
The following feature selection procedure was used. First, a principal component analysis (PCA) was 
performed to account for inter-feature correlations. The number of retained components was adjusted to 
represent 95% of data variance. Next, for each principal component one feature was selected to represent 
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it. To that end we determined the feature that correlated the most (the largest Pearson correlation 
coefficient) with the principal component.  
The prognostic power of radiomic features selected in different implementations was investigated in an 
univariable Cox regression. The models were fitted separately for the USZ and MAASTRO implementations. 
To quantify the discriminative power of different models the concordance indexes (CI) were calculated 
and compared between the implementations. The p-value from Cox regression was corrected for the 
multiple testing using false discovery rate (FDR) < 10% and the number of features defined in the PCA. The 
statistical analysis was performed in R (v. 3.2.3). 
 
Prediction of local tumor recurrence and model reproducibility between the implementations 
To train a final model for the association of the radiomic features derived from post-RCT PET with the 
likelihood of tumor recurrence, the least absolute shrinkage and selection operator (LASSO) (100 times 5-
fold cross-validated) was used for variable selection in multivariable Cox regression. Only the features 
preselected in the PCA were used in the multivariable analysis. A random sampling with replacement was 
used to create a different training set in each of the LASSO iterations. In the final model we included only 
radiomic features with selection rate higher than 70% among all random training sets.  Patients were 
stratified into low- and high-risk of recurrence groups based on a threshold from the receiver operating 
characteristic curve for local recurrence at 18 months. The threshold was selected to equate the level of 
sensitivity and specificity. The groups were compared using G-rho test (p-value < 0.05). Two models were 
trained separately, one on the USZ and one on the MAASTRO feature set. Both models were validated in 
the independent cohort of patients.  
Each trained model, based on the features calculated in one implementation, was later evaluated by 
calculating its respective features with the other independent implementation (Figure 1). The regression 
coefficients of the Cox model and the stratification threshold were then fixed. Model performance was 
quantified using the concordance index (CI). Additionally, the calibration of the models was investigated 
by calculation of the calibration slope based on the prognostic index [19]. The calibration slope equals 1 
evidences the same level of discrimination in the training and validation datasets. Finally, the correlation 
of hazards obtained with two implementations and the reproducibility of the patients risk group 
assignments were investigated. 
 
Results  
Radiomic features reproducibility between the two implementations 
The intraclass correlation coefficient was used to investigate features reproducibility. Out of 649 features, 
46 and 80 were characterized by an ICC greater than 0.9 and 0.8, respectively. These were mostly 
histogram-based (92% of the features in the studied group based on the ICC > 0.8) and texture-based (68%) 
features calculated on the non-transformed images. The shape features showed intermediate 
reproducibility (50%), whereas the biggest discrepancy was observed for the wavelet features (supplement 
Figure 1S). The wavelet features where high-pass filter was applied more than once were the least 
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reproducible. A translation of the 0.5 SUV bin size to the wavelet coefficients was different between the 
implementations (see supplement section Wavelet).  It resulted in a different number of analyzed gray 
levels in the wavelet maps (supplement Figure 3S). Additionally, the MAASTRO implementation uses an 
undecimated transform, whereas the USZ implementation uses the decimated one. This influenced the 
resolution of the analyzed maps.  
 
Figure 2. Comparison of the features’ prognostic power in the univariable Cox regression between the 
radiomics implementations. The fit was considered non-significant if false discovery rate (FDR) > 10%. The 
concordance indexes for the same feature varied between the radiomics implementations and this effect 
did not depend on the feature’s intraclass correlation (ICC) from the implementations comparison. The 
LLL, LLH, LHL, LHH, HHH, HHL, HLH, HLL – denote the combination of wavelet filters in 3D (L – low-pass, H 
– high-pass). 
 
Comparison of the features’ prognostic power between the radiomics implementations 
In the principal component analysis, 31 and 33 components retained the 95% of data variance in the USZ 
and MAASTRO implementation, respectively. We found only 6 representative features based on the 
principal components analysis to be the same for both implementations. In a univariable Cox regression, 
9 features in USZ and 12 features in MAASTRO implementation yielded a FDR < 10%. Among those 
features, more than 50% was not significant in the univariable Cox regression when calculated with 
secondary implementation (Figure 2). Even if the feature was significant in both implementations, a 
substantial difference in CI was observed.  The features were grouped according to their FDR in the 
8 
 
secondary implementation (FDR < 10% or FDR ≥ 10%). No significant difference in the ICC values between 
those groups was observed (Wilcoxon test p-value > 0.05). 
 
Prediction of local tumor recurrence and comparison between the implementations 
In the multivariable analysis, GLCM difference entropy was found to be prognostic in the USZ 
implementation, whereas the histogram range was selected from the MAASTRO implementation. 
Radiomic features in the final local tumor recurrence models showed high level of reproducibility between 
the radiomics implementations (ICC > 0.9). A strong correlation (r > 0.9) between GLCM difference entropy 
and histogram range was observed independent of the implementation. There was a weak, significant 
correlation between selected radiomic features and tumor volume (r < 0.5). 
Both models showed similar prognostic power in the training (5-fold cross-validation) and validation 
cohorts with CI ranging between 0.70 and 0.76 (Table 2) and allowed for a significant risk group 
stratification (Figure 3). In the validation cohort, the calibration slope was not significantly different from 
1, indicating the preservation of model discriminative power (Table 2). Additionally, the models were 
prognostic in the group of HPV negative patients (supplement Figure 4S). In both models, tumors with 
higher risk of recurrence were characterized by a higher post-treatment metabolic heterogeneity 
(supplement Figure 5S).  
 
 Model developed using radiomic features from 
 MAASTRO USZ 
Radiomic features Histogram range GLCM difference entropy 
Intraclass correlation 0.97 0.93 
Concordance Index 
MAASTRO features 
training 0.76 0.75 
validation 0.73 0.73 
USZ features 
training 0.75 0.74 
validation 0.71 0.72 
Calibration slope 
MAASTRO features  1.20 (0.39 – 2.02)* 1.04 (0.27 – 1.95)* 
USZ features  1.13 (0.39 – 1.88)* 1.02 (0.20 - 1.83)* 
Table 2. Performance of PET radiomics models for prediction of local tumor control and the stability of 
radiomic features between two radiomics implementations (USZ and MAASTRO). Underlined values 
indicates results where the same implementation was used for the training of the model and model 
performance evaluation, * 95% confidence interval. 
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The main research question asked in this work was to investigate the model performance when an 
independent radiomics implementation was used to calculate the hazards. Also in this case, the studied 
PET radiomics models achieved a very similar performance in terms of the concordance index as well as 
similar calibration slope (Table 2). It showed that the general discriminative power of the models was not 
affected by the change of the implementation. On the patient level, a strong correlation was observed 
between patient rankings based on the features from both implementations (r > 0.9). Most of the patients 
(around 90%) were correctly classified into low- or high-risk of recurrence group when the independent 
implementation was used (Figure 4).  
 
Discussion 
This study investigated the prognostic value of post-RCT PET radiomics in head and neck squamous cell 
carcinoma and tested the reproducibility of prognostic models between independent radiomics 
implementations (USZ or MAASTRO). Independent of the radiomics implementation used for model 
training, the prognostic model for local tumor control showed a good discriminative power with a 
concordance index higher than 0.7 in both training and validation cohorts. Both models significantly 
stratified patients into low- and high-risk of recurrence groups. Furthermore, the validation of the models 
using an independent radiomics implementation resulted in a similar concordance indexes. However, it is 
important to note that the reproducibility of the models is a consequence of the high ICC between the 
implementations for the selected features. In the modelling process we have observed that the 
discriminative power of single radiomic features preselected for the multivariable analysis depended on 
the radiomics implementation.  
The value of post-treatment FDG-PET imaging for assessment of residual disease is currently unclear [3]. 
Recently, it has been shown in a prospective study that the positive findings on 3 months post-treatment 
FDG PET are a prognostic factor for overall survival and cancer-specific survival [4]. Additionally, our work 
shows that the heterogeneity of 3 months post-RCT FDG activity in the region of primary tumor is related 
to the risk of tumor recurrence. Higher histogram range (range of SUV in the region of primary tumor) and 
higher GLCM difference entropy corresponded to higher risk of tumor recurrence. We have further shown 
that these radiomics models can also significantly stratify the HPV negative patients, who belong  to a 
group with a generally bad prognosis.  Another study found that a pre-treatment FDG PET radiomics has a 
similar prognostic power to our post-treatment model [20]. 
Our prognostic models were trained on a heterogeneous dataset, different PET scanners and 
reconstruction algorithms were used. However, we were able to validate obtained results on a dataset 
with a standardized imaging protocol (the same slice thickness and reconstruction algorithm). Our findings 
should be further validated in datasets from other centers as the lack of calibration between different PET 
scanners can affect the performance of the models [21]. Additionally, we have defined our region on 
interest based on the pre-treatment PET images and propagated it to the post-treatment scan. The model 
reproducibility should be tested against different registration methods for propagation of the delineated 
tumor volume.  
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Figure 3. PET radiomics-based local tumor recurrence models: a) USZ implementation, b) MAASTRO 
implementation. Local control rate curves split significantly (G-rho test p-value < 0.05) in both training 
and validation cohorts based on the optimal sensitivity-specificity thresholds at 18 months. 
 
 
Figure 4. Local control rate curves for low- and high-risk of recurrence groups based on the two PET 
radiomic models. The curves split significantly independent of the implementation 
 (G-rho test p-value < 0.05). 
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The two radiomics implementations used in this study are based on the same mathematical definition of 
radiomic features. Additionally, the image pre-processing (image and region of interest resizing) was 
performed independent of the radiomics implementation and the same bin size was used for image 
discretization [22]. Nevertheless, a relevant variability in radiomic features value was observed, mostly for 
the shape and wavelet features. It was most probably caused by differences in mask construction and 
wavelet transform workflow: especially in the translation of the bin size to the wavelet transformed images 
and the type of transform (decimated vs undecimated). For more details see supplement sections 
Contours mapping and Wavelet.. Variations of contour masks constructed from the same DICOM files is 
also a well-known issue in different treatment planning systems [23]. The comparison of the number of 
analyzed voxels, as well as minimum, maximum and mean value in the GTV  between two radiomics 
implementations is shown in Figure 2S. The GTV constructed with USZ implementation was always larger 
then in MAASTRO implementation and consequently the minimum SUV in USZ implementation was always 
lower. Regarding wavelet transform, the two implementations transferred differently the bin size of 0.5 
SUV into the wavelet coefficients space, which resulted in different number of analyzed gray levels (Figure 
S3). A separate study investigating a discriminative power of wavelet features obtained with the two gray 
level discretization methods could be conducted to clarify which method is more informative in the context 
of medical image analysis This study points out differences in radiomics workflow steps, which are rarely 
described in radiomics studies. Therefore, clear guidelines, such as the Image Biomarker Standardization 
Initiative [24], providing detailed description of radiomics workflow and implementation are needed. For 
a workflow comparison purpose, we are also open to share our source code upon request. Nonetheless, 
we showed that the majority of histogram and texture features was reproducible (i.e. high ICC values) 
despite the existing differences in contours mask construction. This result suggests that the mask creation 
is only a minor concern in the standardization aiming for the reproducibility of patients ranking and model 
prognostic power. 
Our final prognostic models for local tumor recurrence were reproducible when the features from the 
independent radiomics implementation were used, which can be explained by the fact that both models 
consisted of radiomic features with a high ICC in the comparison between the implementations (ICC > 0.9). 
Most of the available radiomic features showed a much lower agreement in this comparison. A large 
variation in concordance indexes was observed for the radiomic features preselected in the principal 
component analysis. Most of the features preselected in one implementation were not significantly 
associated with local tumor recurrence in the other implementation in the univariable analysis. This shows, 
for the first time on a clinically relevant model and dataset, that a model developed by one institution 
should not be directly transferred to another center, which uses a different radiomics implementation, 
without rigorous comparison. We recommend that each model, additionally to a detailed description of 
the radiomics implementation, should be published with a sample dataset and corresponding radiomics 
signature, such as a recently published digital phantom [25]. This will allow for a comparison of results 
obtained from a model, before it will be used in a prospective cohort.  
In conclusion, this study shows the potential of post-RCT FDG-PET radiomics for early identification of 
patients with a high risk of local tumor recurrence. It also raises an awareness of the impact of radiomics 
software implementation on model reproducibility.  
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